A Phase 1 Study of YZJ-4729 Tartrate Injection in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 12, 2022

Primary Completion Date

April 14, 2023

Study Completion Date

September 22, 2023

Conditions

Postoperative Analgesia

Interventions

DRUG

YZJ-4729 Tartrate injection

Infusion, QD

DRUG

YZJ-4729 simulated injection

Infusion, QD

Trial Locations (1)

Xiangya Third Hospital, Central South University, Changsha

All Listed Sponsors

lead

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

INDUSTRY